Oral Drug Delivery Videos

  1. Nanoforming: The Patient- And Planet-Centric Approach

    By reducing the size of drug particles, nanoforming can open up new opportunities – from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies.

  2. Solid Form Screening Of Active Pharmaceutical Ingredients

    Explore the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

  3. KinetiSol® Technology: Scale Up Approach 3/19/2024

    Process parameter and quality attribute relationships, including those for typical pre and post KinetiSol unit operations, will be explored in the context of real-world examples.

  4. Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying

    Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

  5. Real World Dosing Solutions For Patients 1/23/2018

    Orally disintegrating tablets enhance pharmacokinetics and improve compliance. Zydis® fast dissolve can enhance your investment and increase your product’s potential.

  6. Increasing Spray Drying Throughput For Brick Dust Compounds

    ‘Brick dust’ compounds require additional steps if spray drying is to yield a commercially attractive process. Explore three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

  7. Integrated Strategies For Poor Solubility, Modified Release & Pediatrics 6/8/2022

    Through case studies on modified release, poor solubility, and pediatrics, discover how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines for even the most challenging of molecules.

  8. Nanoform Capacity Update June 2023: Small Molecule 6/21/2023

    Sergie Letser, Deputy CCO, SVP Business Development, presents an overview of Nanoform’s award winning CESS® technology capabilities which solves solubility, bioavailability, and formulation challenges in development.

  9. PBPK Modeling: Mitigating Absorption Risks In Early Drug Development

    Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

  10. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.